Development of an AlphaLISA protein-protein interaction assay to screen for re-purposed drugs as targeted disruptors
Read how an AlphaLISA protein-protein interaction assay helps to screen for re-purposed drugs as targeted disruptors for the interaction between ACE2 and SARS-CoV-2 spike protein.

